Pliant Therapeutics (9PT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Pln-101095 | Advanced Or Metastatic Solid Tumor | Phase I | Recruiting | A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors | Jan 26, 2024 | ― |
| Pln-74809 | Idiopathic Pulmonary Fibrosis | Phase II | Terminated | Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis | Oct 18, 2023 | ― |
| Pln-74809 | Idiopathic Pulmonary Fibrosis | Phase II | Completed | Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) | Nov 02, 2022 | ― |
| Pln-74809 | Primary Sclerosing Cholangitis | Phase II | Completed | Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) | Jul 13, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Pln-101095 | Phase I | Advanced Or Metastatic Solid Tumor | Recruiting | A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors | Jan 26, 2024 | ― |
| Pln-74809 | Phase II | Idiopathic Pulmonary Fibrosis | Terminated | Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis | Oct 18, 2023 | ― |
| Pln-74809 | Phase II | Idiopathic Pulmonary Fibrosis | Completed | Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) | Nov 02, 2022 | ― |
| Pln-74809 | Phase II | Primary Sclerosing Cholangitis | Completed | Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) | Jul 13, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pliant Therapeutics, Inc. (DE:9PT) have in its pipeline
Pliant Therapeutics DE:9PT is currently developing the following drugs: Pembrolizumab, Pln-101095, Pln-74809. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
